TABLE 3.

Factors associated with discordant results between tests in the univariate analysis

	OR (95% CI)	p-value
Age
<65 years	1	0.92
≥65 years	1.05 (0.4–2.71)
Sex
Female	1	0.92
Male	1.05 (0.4–2.71)
Type of cancer diagnosis by location
Haematologic	0.92 (0.19–4.42)	0.92
Nonhaematologic#	1
Cancer status
Partial or complete remission	1	0.84
Current management with palliative or curative chemotherapy¶	1.67 (0.54–5.18)
Current management with other treatments	1.81 (0.41–7.98)
Progression, with follow-up	0.98 (0.19–5.2)
Initial staging, before the beginning of treatment	1.96 (0.35–11.17)
Scar of BCG vaccine
Yes	0.65 (0.25–1.71)	0.39
No	1
Comorbidities associated with immunosuppression
Treatment with other immunosuppressants	1.98 (0.69–5.78)	0.43
Corticosteroid use for >90 days	4.25 (0.69–26.22)
Insulin-dependent diabetes	2.83 (0.27–29.9)
History of haematopoietic stem cell transplant	2.83 (0.27–29.9)
None	1
Lymphopenia
Yes	0.99 (0.26–3.81)	0.99
No	1

BCG: bacille Calmette–Guérin. ^#: nonhaematologic cancers were grouped for analysis; ^¶: cases of management with palliative and curative chemotherapy were grouped for analysis.